0001354488-13-006674.txt : 20131129 0001354488-13-006674.hdr.sgml : 20131128 20131129111221 ACCESSION NUMBER: 0001354488-13-006674 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131129 DATE AS OF CHANGE: 20131129 EFFECTIVENESS DATE: 20131129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-207209 FILM NUMBER: 131249479 BUSINESS ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-806-4414 MAIL ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 FORMER COMPANY: FORMER CONFORMED NAME: FEDERATED FRANCHISES INC DATE OF NAME CHANGE: 19760907 D 1 primary_doc.xml X0707 D LIVE 0000034956 OXYGEN BIOTHERAPEUTICS, INC. ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC NORTH CAROLINA 27560 919-855-2100 DELAWARE SYNTHETIC BLOOD INTERNATIONAL INC SINEQUANON CORP FEDERATED FRANCHISES INC Corporation true John Kelley ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Executive Officer Michael B Jebsen ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Executive Officer Ronald R Blanck ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Gregory Pepin ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director William A Chatfield ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Chris A Rallis ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Anthony A DiTonno ONE Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Director Pharmaceuticals $1,000,001 - $5,000,000 06b false 2013-11-13 false true true Company's acquisition of certain assets of Phyxius Pharma, Inc. on 11/13/13. The Company issued 1,366,844 shares of common stock and 32,992 shares of Series E convertible preferred stock (convertible into 3,299,200 shares of common stock). 0 6579122 6579122 0 Based on $1.41 per share on 10/18/13, and the Company issuing approximately 4.7 million shares of common stock and preferred stock convertible into common stock. false 4 0 0 0 false OXYGEN BIOTHERAPEUTICS, INC. /s/ Michael B. Jebsen Michael B. Jebsen Chief Financial Officer 2013-11-27